ReviewCancer management and research2020

A Review About Pembrolizumab in First-Line Treatment of Advanced NSCLC: Focus on KEYNOTE Studies.

Jialin Qu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.